The FDA has granted a de novo clearance to a wearable device—with a form factor you’re familiar with—that can check patients ...

In a pivotal stride to address the growing AFib epidemic, OMRON Healthcare today announced the U.S. Food and Drug ...

OMRON Healthcare has received de novo authorization from the U.S. Food and Drug Administration (FDA) to market new home blood pressure monitors featuring AI-powered atrial fibrillation ...

The REACT-AF trial began in July 2023 and is led by researchers at Johns Hopkins Medicine. Randomized patients (half of the ...

Adding an extra hour every week of physical activity may lower the chance of developing the most common type of irregular heartbeat (arrythmia) by 11 percent, a new study shows.

Boston Scientific is resuming its "Avant Guard" study of pulse field ablation (PFA) as a first-line therapy for atrial ...

Exposure to extreme heat may double or triple the risk of irregular heart rhythms in people with implanted defibrillators, ...

Fourth Frontier has achieved a crucial milestone with the FDA's clearance of the Frontier X Plus, a single-lead ECG monitor. Positioned to enhance heart health monitoring, this wearable device ...

SAN ANTONIO — Most of us know that as we age we become more and more prone to medical ailments. But one ailment in particular may be becoming more common. We Verify. We've heard that as a ...

After multiple medical procedures starting in May 2022, Arthur Schiebel was pleased to have his atrial fibrillation under control. He was less pleased to find out he’d need to take blood ...

Fourth Frontier, a medical technology company based out of New York and Bangalore, announced the 510(k) clearance of the ...

Late last month, Boston Scientific announced it was pausing a study examining pulsed field ablation as a first-line therapy.